HFpEF: a diverse, real-world group to understand heart failure with preserved ejection fraction
Official title: A prospective multiethnic HFpEF cohort from Californias Central Valley
Funded at University of California at Davis · NIH-11531627 · Data updated 2026-11-12
A diverse group of people with HFpEF in California is being enrolled to learn more about the condition through detailed medical analyses.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 10, 2021 |
| Project end | December 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $427,455 |
| NIH project number | 3U01HL160274-05S2 |
| Project ID | NIH-11531627 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with HFpEF who are or could be enrolled in the HeartShare Registry across participating sites.
✕Less likely to help
Patients with HFpEF who are not enrolled in the registry or who do not consent to deep phenotyping may not directly benefit.
What this research studies
This project recruits HFpEF patients from UC Davis and other sites to build a large, multiethnic cohort for deep phenotyping. Researchers will enroll participants weekly and collect rich clinical data to understand how HFpEF manifests across different populations. The study also supports a HeartShare Registry, expanding opportunities for future research and patient involvement. Analyses will explore how organ systems interact and how treatments may affect clinically meaningful outcomes.
Why it matters
Potential benefit: If successful, findings could lead to more personalized care for HFpEF and better risk prediction across diverse groups.
How similar studies have gone: Previous HFpEF cohorts have shown that large, diverse datasets improve understanding of disease variability and treatment responses.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Chiamvimonvat, Nipavan — University of California at Davis
- Study coordinator: Chiamvimonvat, Nipavan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.